02552 HUA MEDICINE-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 4.05X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | N/A | Net Margin | N/A |
Total Debt/Equity | N/A | Return on Equity | N/A |
Price/Book | N/A | Return on Assets | N/A |
(HKD 3.900) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -266.03 | -232.82 | -228.17 | -398.41 | -466.57 |
---|---|---|---|---|---|
Net Profit Growth (%) | -14.3 | -2.0 | +42.7 | +14.6 | +1.9 |
Earnings Per Share (HKD) | -0.271 | -0.238 | -0.236 | -0.416 | -0.491 |
Earnings Per Share Growth (%) | -13.8 | -1.0 | +43.3 | +15.2 | +2.7 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | -0.137 | 0.106 | 0.297 | 0.522 | 0.824 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 255.892 | 76.61 | +234.0 | 17.599 |
Operating Result | -250.144 | -211.234 | +18.4 | -203.507 |
Profit Before Taxation | -250.144 | -211.234 | +18.4 | -203.507 |
Profit /( Loss) After Taxation | -250.144 | -211.234 | +18.4 | -203.507 |
Net Profit | -250.144 | -211.234 | +18.4 | -203.507 |
Earnings Per Share () | -0.2711 | -0.2383 | +13.8 | -0.2360 |
Announcement Date | 2025-03-27 | 2024-03-28 | NA | 2023-03-29 |
* Annualised
Last Update Time: 2025-07-22 21:40:25